Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

VMS Market Regulation Gets Targeted Funding In US FDA Budget; OTC Switches Get Question

Mar 16 2022

• By Malcolm Spicer

• Source: Alamy

Related Content

Regulation Of US Supplement Industry Needs ‘Really Hard Look’ – FDA's Woodcock

Sep 10 2021

Schumer Includes Cannabinoid Pathway For Supplements In Cannabis Legalization Draft Bill

Jul 14 2021

US House Appropriators Keep A Bullseye On FDA’s CBD Regulation Development

Jul 07 2020

Making Progress On Novel OTC Switch Rulemaking Has FDA Commissioner Nominee Califf’s Attention

Jan 12 2022

Facilitating More OTC Switches In US Graduates To Regulatory Plan On FDA’s Unified Agenda

Jan 03 2022

Califf Returns To US FDA Helm As Familiar Consumer Health Regulation Problems Continue

Feb 16 2022

Additional Topics

International United States Dietary Supplements FDA Prescription To OTC Switch Cannabidiol CBD Commercial Compliance Consumer Cosmetics Enforcement Financing Ingredients Legislation Manufacturing OTC Devices OTC Drugs Politics Policy Regulation Review Pathway

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window